Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/234.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.)
Description: Subject matter involving a bacterium, a component of a bacterium, or a substance produced by a bacterium.










Sub-classes under this class:

Class Number Class Name Patents
424/246.1 Bacillus 145
424/253.1 Bordetella (e.g., bordetella bronchiseptica, etc.) 84
424/252.1 Brucella (e.g., brucella abortus, brucella canis, etc.) 37
424/263.1 Chlamydia (e.g., chlamydia trachomatis, etc.) 125
424/247.1 Clostridium (e.g., clostridium tetani, clostridium difficile, clostridium perfringens, clostridium botulinum, clostridium chauvoei, etc.) 222
424/245.1 Corynebacterium (e.g., corynebacterium diphtheriae, etc.) 54
424/257.1 Escherichia (e.g., escherichia coli, etc.) 188
424/256.1 Hemophilus (e.g., hemophilus influenzae, hemophilus gallinarum, hemophilus pleuropnemoniae, etc.) 236
424/259.1 Klebsiella (e.g., klebsiella pneumoniae, etc.) 39
424/251.1 Moraxella (e.g., moraxella bovis, etc.) 70
424/248.1 Mycobacterium (e.g., mycobacterium tuberculosis, calmette-guerin bacillus (i.e., bcg), etc.) 425
424/264.1 Mycoplasma 68
424/249.1 Neisseria (e.g., neisseria gonorrhoeae, etc.) 139
424/255.1 Pasteurella (e.g., pasteurella multocida, pasteurella hemolytica, etc.) 109
424/242.1 Pilus, fimbria, or adhesin 95
424/260.1 Pseudomonas (e.g., pseudomonas aeruginosa, etc.) 121
424/258.1 Salmonella (e.g., salmonella typhimurium, etc.) 193
424/243.1 Staphylococcus (e.g., staphylococcus aureus, etc.) 184
424/244.1 Streptococcus (e.g., group b streptococcus, pneumococcus or streptococcus pneumoniae, etc.) 422
424/236.1 Toxin or toxoid, except endotoxin (e.g., exotoxin, enterotoxin, etc.) 540
424/235.1 Transposon mutant or deletion mutant bacterium (e.g., produced by transposon mutagenesis, etc.) 128
424/262.1 Treponema (e.g., treponema hyodysenteriae, treponema pallidum, etc.) 47
424/261.1 Vibrio (e.g., vibrio cholera, etc.) 106


Patents under this class:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next

Patent Number Title Of Patent Date Issued
7569226 Alkaline protease from Bacillus sp. (DSM 14392) and washing and cleaning products comprising said alkaline protease Aug. 4, 2009
7566459 Modified mycobacterium tuberculosis strains and uses thereof Jul. 28, 2009
7563878 Bacterial phytases and method for producing same Jul. 21, 2009
7556816 Ehrlichia chaffeensis 28 kDa outer membrane protein multigene family Jul. 7, 2009
7556810 Compositions and methods to control angiogenesis with cupredoxins Jul. 7, 2009
7553490 Vaccines against Escherichia coli O157 infection Jun. 30, 2009
7550270 Ileitis diagnostic assay Jun. 23, 2009
7547527 Use of probiotic lactic acid bacteria for balancing the skin's immune system Jun. 16, 2009
7541041 Vaccine against dental caries based on virulence-associated immunomodulatory extracellular proteins produced by the cariogenic bacteria Streptococcus sobrinus and Streptococcus mutans Jun. 2, 2009
7541039 Immunization with bacterial ghost-based vaccines Jun. 2, 2009
7538208 Type III secretion pathway in Aeromonas salmonicida, and uses therefor May. 26, 2009
7538206 Comparative mycobacterial geneomics as a tool for identifying targets for the diagnosis, prophylaxis or treatment of mycobacterioses May. 26, 2009
7538083 Compositions and methods for the potentiation of immune responses against target antigens May. 26, 2009
7534857 Methods and compositions for the treatment and prevention of staphylococcal infections May. 19, 2009
7534444 Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies May. 19, 2009
7534443 Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient May. 19, 2009
7531183 Biologically active hemagglutinin from type A Clostridium botulinum and methods of use May. 12, 2009
7531177 Surface protein of leptospira May. 12, 2009
7531176 Brachyspira pilosicoli 72 kDa outer-membrane protein and diagnostic and therapeutic uses thereof May. 12, 2009
7531163 Enrichment methods for the detection of pathogens and other microbes May. 12, 2009
7527802 Vaccine for transcutaneous immunization May. 5, 2009
7527797 Vibrio cholerae 0139 conjugate vaccines May. 5, 2009
7524509 Proteosome-liposaccharide vaccine adjuvant Apr. 28, 2009
7524507 Recombinant microorganisms Apr. 28, 2009
7521060 Pathogen for bacterial poultry disease Apr. 21, 2009
7521059 Kennel cough vaccine Apr. 21, 2009
7521040 Immunotherapy for humans Apr. 21, 2009
7517955 Streptococcus uberis adhesion molecule Apr. 14, 2009
7517862 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends Apr. 14, 2009
7517666 Methods of inhibiting Helicobacter pylori Apr. 14, 2009
7517533 Pseudomonas aeruginosa antigens Apr. 14, 2009
7514088 Multivalent Clostridial toxin derivatives and methods of their use Apr. 7, 2009
7510717 Non-toxic mutants of pathogenic gram-negative bacteria Mar. 31, 2009
7507419 Topically applied Clostridium botulinum toxin compositions and treatment methods Mar. 24, 2009
7504111 Gonococcal proteins and nucleic acids Mar. 17, 2009
7504110 Protein-based Streptococcus pneumoniae vaccines Mar. 17, 2009
7501132 Multiple antigenic peptides immunogenic against Streptococcus pneumonia Mar. 10, 2009
7501131 Haemophilus influenzae type IV pili Mar. 10, 2009
7498046 Composition for inducing immune response comprising inverted microsomes Mar. 3, 2009
7494661 Methods for using tetanus toxin for beneficial purposes in animals (mammals) Feb. 24, 2009
7491404 Acellular immunogenic compositions and acellular vaccine compositions against Bacillus anthracis Feb. 17, 2009
7491403 Pharmaceutical botulinum toxin compositions Feb. 17, 2009
7491401 Lawsonia intracellularis vaccine Feb. 17, 2009
7491395 Compositions comprising antigen-complexes, method of making same as well as methods of using the antigen-complexes for vaccination Feb. 17, 2009
7488488 Tick chitinase Feb. 10, 2009
7488487 Methods of inducing immune responses through the administration of auxtrophic attenuated dal/dat double mutant Listeria strains Feb. 10, 2009
7485313 Recombinant Chlamydia trachomatis pgp3 protein suitable for enzyme-linked immunoassay, and used of the protein in eliciting and diagnosing an immune response Feb. 3, 2009
7485304 Non-toxic mucosal adjuvant Feb. 3, 2009
7479283 Acellular pertussis vaccine comprising a combination of the 69 kDa and the filamentous haemagglutinin antigens of Bordetella pertussis Jan. 20, 2009
7479282 Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof Jan. 20, 2009

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next










 
 
  Recently Added Patents
Method and apparatus for optimizing paging in a communication network
Eyeglasses
Probe for ultrasound diagnostic apparatus
Device and method for adjusting a chrominance signal based on an edge strength
Selecting one of a plurality of print modes based on pixel coverage of a document
Wafer level packaging structure with large contact area and preparation method thereof
Shoe
  Randomly Featured Patents
Laser beam scanning type eye fundus observing device
Solid polymer electrolytes using polyether poly (N-substituted urethane)
Maleic anhydride recovery
Bag
Method and apparatus for making battery grids
Safety switch
Sucker rod string
Methods and compositions for screening for human Borna disease virus
Novelty cigar gauge and measuring apparatus
Matrix multiplier